NMS · Biotechnology

RIGL (RIGL) Stock

$38.51 +0.03% NMS: RIGL Healthcare

Valuation

MetricValue
Price$38.51
Market Cap$712.52M
P/E Ratio1.45
P/B Ratio1.34
P/S Ratio1.77
EPS (TTM)$19.48
52-Week High$52.24
52-Week Low$18.14
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE93.86%
ROA71.40%
ROCE31.89%
Gross Margin42.52%
Operating Margin42.52%
Net Margin1.22%
Debt/Equity0.11
Current Ratio2.42

Annual Financials (USD)

Metric20212022202320242025
Revenue$149.0M$120.0M$117.0M$179.0M$294.0M
Operating Profit$-12.0M$-56.0M$-20.0M$24.0M$125.0M
Net Profit$-18.0M$-59.0M$-25.0M$17.0M$367.0M
EPS$-1.10$-3.40$-1.44$0.99$19.48
Op Margin-8.4%-46.2%-17.5%13.5%42.6%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$167.0M$134.0M$117.0M$164.0M$514.0M
Total Liabilities$137.0M$148.0M$146.0M$161.0M$122.0M
Cash$19.0M$24.0M$33.0M$57.0M$41.0M
Borrowings$31.0M$42.0M$61.0M$60.0M$53.0M

Latest News

Bioventus (BVS) Soars 12.4%: Is Further Upside Left in the Stock? Zacks · Jul 7, 2026 Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) PR Newswire · Jul 7, 2026 Rigel Appoints Board Member Alison L. Hannah, M.D. as Chief Medical Officer PR Newswire · Jul 1, 2026 Rigel Pharmaceuticals Closes Licensing Deal for Breast Cancer Drug Veppanu MT Newswires · Jun 16, 2026 Rigel Announces Closing of Licensing Agreement for VEPPANU™ (vepdegestrant) PR Newswire · Jun 16, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$6.0M$-74.0M$-6.0M$31.0M$76.0M
Investing Cash Flow$-81.0M$72.0M$-19.0M$4.0M$-92.0M
Financing Cash Flow$63.0M$-13.0M$-2.0M$-12.0M$0
Net Cash Flow$-11.0M$6.0M$8.0M$24.0M$-16.0M
Free Cash Flow$5.0M$-74.0M$-21.0M$31.0M$76.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA4.22
FCF Yield14.95%
Quick Ratio2.48
Interest Coverage17.86
Return 1Y74.75%
Return 3Y189.92%
Return 5Y0.66%

Ownership

Insiders Held3.39%
Institutions Held94.11%
Institutions Float Held97.41%
Institutional HolderSharesReport Date
Blackrock Inc.1,768,9072026-03-31
Armistice Capital, LLC1,280,0002026-03-31
State Street Corporation1,120,2382026-03-31
Vanguard Capital Management LLC764,1932026-03-31
Acadian Asset Management. LLC666,4262026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AKBA $1.31 -0.76% -45.00 $351.42M 0.00%
BCYCBicycle Therapeutics plc $4.22 +0.24% -1.34 $292.84M 0.00%
CRVS $13.31 +3.02% -23.00 $1.12B 0.00%
FDMT $10.09 -0.88% -3.47 $527.47M 0.00%
GOSSGossamer Bio, Inc. $0.19 +38.24% -0.17 $44.10M 0.00%

About RIGL

RIGL is led by CEO Raul R. Rodriguez, employs 162 people, headquartered in US, publicly traded since 2000.

RIGL stock trades at $38.51 with a market capitalization of $712.52M. The stock is valued at a price-to-earnings (P/E) ratio of 1.45, price-to-book of 1.34, price-to-sales of 1.77. Over the past 52 weeks the stock has ranged between $18.14 and $52.24, and currently trades 26.3% below its 52-week high.

On profitability, RIGL generates a return on equity (ROE) of 93.86% — well above the market average, a sign of a high-quality business, return on capital employed of 31.89%, an operating margin of 42.52%, a net profit margin of 1.22%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides